Structural Heart Disease: Out-of-hospital mortality & TAVR | Expanded coverage for TEER | TAVR & COVID-19

Researchers examined data from more than 98,000 patients who underwent transfemoral TAVR from January 2015 to March 2018. 

Abbott described the update as "critically important," and the American College of Cardiology expressed relief that some proposed changes did not actually end up happening. 

Two specialists have shared their own perspective on the updated ACC/AHA guidelines in Circulation.

Researchers compared patient outcomes from 2019 with data from the pandemic’s first four months, sharing their findings in the American Journal of Cardiology.  

According to new data from the ongoing COMMENCE clinical trial, patients showed no signs of structural valve deterioration after five years.

Patients are typically told to put anticoagulation therapy on hold two to four days before they undergo TAVR. This study’s authors aimed to see if this was truly necessary.  

The authors examined data from more than 42,000 patients who received care from 2012 to 2017. 

Post-discharge stroke rates, however, were similar between the two procedures.

This new position paper is a collaboration between representatives from the European Society of Cardiology and International Society for Adult Congenital Heart Disease.

The system was designed to require only one small incision to repair a patient’s mitral valve.